0001193125-26-115851
SEC filingNo Notes data available in provided document section.
Aveanna Healthcare Holdings Inc. describes itself as 'a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations.' The company directly addresses healthcare system challenges by delivering safe, high-quality care in the home, a lower-cost setting preferred by patients. Its clinical model is led by skilled nurses who provide specialized care across all patient populations: newborns, children, adults, and seniors. The company commenced operations in March 2017 following the merger of Epic Health Services and Pediatric Services of America, and is headquartered in Atlanta, Georgia.
Aveanna operates through three reporting segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).
Aveanna's technology infrastructure includes several named platforms: iCIMS for recruiting and onboarding; CellTrak EVV for electronic visit verification; Aveanna Hope Devices for mobile care reporting; Netsmart myUnity, Homecare Homebase, and Brightree Cloud for clinical workflows in PDS, HHH, and MS respectively; GLS, Homecare Homebase, and Brightree for revenue cycle management; and Workday for enterprise resource planning (financial, payroll, HR). The company also deploys remote care management tools and automated patient scheduling systems.
Referral sources are primarily hospitals, especially children's hospitals for PDN. The company builds long-term relationships with provider partners (hospitals and health systems) and payers. It offers a 'one-stop shop' range of clinical services. Reimbursement sources are highly diverse, with more than 1,500 distinct payers across 38 states, including Medicaid managed care organizations (MCOs), state-based Medicaid programs, Medicare, Medicare Advantage plans, and commercial insurance. The majority of PDN patients are covered by Medicaid fee-for-service or MCOs. Adult home health and hospice services are primarily reimbursed by Medicare and Medicare Advantage.
The private duty services industry is highly competitive and fragmented, with competitors ranging from facility-based agencies to independent homecare companies. Aveanna's primary competitors in home health include hospital-based agencies and local agencies, both for-profit and not-for-profit. The home health market has over 12,000 Medicare-certified agencies according to MedPac. The medical solutions industry is also highly fragmented and market-specific, with few national competitors. Competition is based on caregiver availability, quality, expertise, and service value. Entrants include privately and publicly held organizations and not-for-profits.
Aveanna's growth strategy includes five pillars: (1) Increasing volumes within existing footprint by leveraging its 'virtuous cycle' of scale advantages, referral source education, and de novo branch growth; (2) Leveraging scale to drive value-based care arrangements with managed care payer partners, sharing in savings and improving outcomes; (3) Expanding through acquisitions—both tuck-in (small, highly synergistic) and expansion (larger, diversifying geography), with integration times measured in weeks to months; (4) Cross-selling enteral services to its PDN and home care patient base, as most PDN patients also require enteral therapy but are often served by other providers; (5) Reinvesting in its platform (people, technology, processes) to drive efficiency and support data-driven results, including reporting capabilities for value-based payment models.
As of January 3, 2026, Aveanna employed approximately 32,000 individuals, of which about 3,500 are full-time support staff. The remaining employees work on a part-time, temporary, per-diem, or full-time basis. No employees are union members or subject to collective bargaining agreements. The company emphasizes talent acquisition, retention, and development through a candidate-focused, technology-driven recruiting experience. It maintains an Inclusion & Engagement (I&E) strategic initiative with an executive committee, annual summit, inclusion ambassadors, enterprise-wide training, employee engagement surveys, and connection groups to foster an inclusive workplace.
No balance sheet data from Notes section.
No commitment data from Notes section.
No capital allocation data from Notes section.
No segment data from Notes section.
The most material risks revolve around government reimbursement. CMS cut Medicare home health rates by 1.3% for FY2026, and the OBBBA reduces Medicaid funding and tightens eligibility. Sequestration continues to reduce Medicare payments by 2%. These changes directly pressure revenue and profitability. Additionally, managed care trends and value-based purchasing models could further constrain reimbursements. The company's limited ability to control costs in a fixed-rate environment amplifies this risk.
A chronic shortage of qualified nurses and caregivers, especially LPNs, drives up labor costs and turnover. The company competes with hospitals and other providers for this pool. Inability to attract and retain staff can reduce service capacity and quality. Weather events and public health emergencies also pose operational disruption risks.
The healthcare industry is heavily regulated. Non-compliance with Anti-Kickback, Stark, HIPAA, and other laws can result in exclusion from Medicare/Medicaid, fines, and criminal penalties. Ongoing audits (RAC, TPE, UPIC) increase scrutiny. New data privacy regulations (e.g., CCPA) add compliance costs. Any violation could materially harm the business.
Cybersecurity attacks are increasing in frequency and sophistication. Past incidents have occurred. A breach could lead to loss of sensitive patient data, regulatory penalties, litigation, and reputational damage. Reliance on complex IT systems for billing, scheduling, and clinical documentation creates additional vulnerabilities.
The company carries $1.487B in debt, primarily variable-rate, exposing it to interest rate fluctuations (partially hedged). Goodwill and intangible assets constitute 60% of total assets, subject to impairment if performance falters. Leverage restricts strategic flexibility. Acquisitions (like Thrive) involve integration risks and potential unforeseen liabilities.
Intense competition from national chains, local providers, and non-profits erodes market share. Referral relationships are non-contractual and can be lost. Managed care consolidation gives payers leverage to negotiate lower rates. Any of these could adversely impact revenue.
Sponsors control 57.7% of equity, enabling them to significantly influence decisions, including potential conflicts of interest. Controlled company exemptions reduce independent oversight. Anti-takeover provisions in the charter may deter beneficial acquisitions. The company does not pay dividends, so stock price appreciation is the sole return mechanism.